NCT06890312View on ClinicalTrials.gov

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

NARecruitingINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Coronary AngiographyPercutaneous Coronary InterventionRadial Artery OcclusionBleedingAnticoagulation
Interventions
PROCEDURE

Administration of heparin after sheath insertion

Administration of heparin after sheath insertion

PROCEDURE

Administration of heparin prior to sheath insertion

Administration of heparin prior to sheath insertion

Trial Locations (1)

67091

RECRUITING

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT06890312 - Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention) | Biotech Hunter | Biotech Hunter